Asia-Pacific Americas Africa Europe Middle East

BORA PHARMACEUTICAL LABORATORIE

Company Profile:



Business Nature: Manufacturer (CDMO - Contract Development and Manufacturing Organization)

Company Overview:

Bora Pharmaceutical Laboratories is a leading international pharmaceutical manufacturer based in Taiwan. It specializes in providing comprehensive contract development and manufacturing organization (CDMO) services for the global pharmaceutical industry. The company operates state-of-the-art manufacturing facilities that comply with international regulatory standards, including US FDA, EU EMA, and TFDA certifications.

Core Capabilities:

1. Product Development: Expertise in complex formulation and process development.

2. Manufacturing: Large-scale production of various dosage forms including oral solids (tablets and capsules), liquids, creams, and ointments.

3. Quality Assurance: Rigorous quality control systems ensuring global regulatory compliance.

4. Supply Chain: Extensive experience in global logistics and supply chain management, serving markets across North America, Europe, and Asia.

Strategic Focus:

Bora Pharmaceutical focuses on expanding its global footprint through strategic acquisitions and high-end technical capabilities. It serves as a trusted partner for multinational pharmaceutical companies, helping them bring high-quality medicines to patients worldwide. The company is recognized for its operational excellence, technical proficiency, and commitment to maintaining the highest standards of pharmaceutical manufacturing.

Enterprise Products

BORA Pharmaceutical Laboratories, based in Taiwan, produces and sells a diverse range of pharmaceutical products. These include products manufactured for other companies as a Contract Development and Manufacturing Organization (CDMO) and its own branded or distributed products, often through strategic acquisitions.

CDMO Manufacturing Capabilities (Products produced for clients):

Oral Solid Dosages: Tablets (immediate release, extended release, chewable, orally disintegrating), Capsules (hard gelatin, soft gelatin), Powders, Granules.

Oral Liquid Dosages: Solutions, Suspensions, Syrups.

Semi-Solid Dosages: Creams, Ointments, Gels.

Sterile Injectable Products: Vials, Pre-filled Syringes, Ampoules for biologics and small molecules.

Active Pharmaceutical Ingredients (APIs).

Branded and Distributed Products (Products sold under Bora's portfolio or distributed by Bora in Taiwan):

Specialty Generics: Products for various therapeutic areas including dermatology, ophthalmology, central nervous system, and cardiovascular diseases, primarily through its acquired subsidiary TWi Pharmaceuticals.

Dermatological Products: Creams, ointments, and gels for various skin conditions.

Ophthalmic Products: Eye drops and other formulations for eye care.

Respiratory Products: Examples include Ventolin and Seretide, distributed in Taiwan.

Vaccines: Examples include Fluarix and Infanrix, distributed in Taiwan.

Consumer Healthcare Products: Examples include Panadol (pain relief), Sensodyne (oral care), and Voltaren (pain relief), distributed in Taiwan.

Other Therapeutic Areas: Including cardiovascular, oncology, and central nervous system products.

Business Registration Information:

Manager:

Bobby Sheng

Phone:

No Data

E-mail:

info@bora-corp.com

Official Website:
Address:

2F., No. 168, Sec. 2, Nanjing E. Rd., Zhongshan Dist., Taipei City 104, Taiwan (R.O.C.)

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.